The Recall Desk
Agency classClass IIOur severity:SevereFDA (Drugs)·D-0173-2019·Announced 2018-11-07

Pharm D Solutions Recalls Prostaglandin E1 Injectable Due to Sterility Concerns

Pharm D Solutions is recalling Prostaglandin E1 150 mcg/mL Injectable because the agency could not ensure the product was sterile.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The FDA classified this recall as Class II. According to the rubric, an FDA Class II recall with potential for adverse health consequences (sterility issues in injectables) maps to a score of 4 (Severe), as it is not Class I (Critical) but involves significant risk.

Plain-English summary

Pharm D Solutions, LLC is recalling Prostaglandin E1 150 mcg/mL Injectable (NDC 69699-1623-05) due to a lack of assurance of sterility. The recall involves 193 milliliters of the product distributed nationwide.

The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

Consumers and healthcare providers should stop using the recalled product and contact Pharm D Solutions, LLC or their healthcare provider for further instructions. Specific lot numbers and discard dates are listed in the official recall notice.

The recalled product

Product
Prostaglandin E1 150 mcg/mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1623-05
Manufacturer
Pharm D Solutions, LLC
Category
Drug — Injectable
Hazard
Affected units
193

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (7)

  • Lot: 04262018:18 Discard by: 10/22/2018
  • 03292018:66 Discard by: 9/24/2018
  • 05312018:19 Discard by: 11/27/2018
  • 07022018:55 Discard by: 12/29/2018
  • 06122018:51 Discard by: 12/9/2018
  • 07242018:71 Discard by: 1/20/2019
  • 08302018:90 Discard by: 2/23/2019

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 79 recalled by Pharm D Solutions, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 79 products in this recall →

Related recalls

Same manufacturer · Pharm D Solutions, LLC

See all →

Same hazard · sterility

See all →

Similar recalls